{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:53:23Z","timestamp":1793843603391,"version":"4.6.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health &amp; Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 CA090321"],"award-info":[{"award-number":["RO1 CA090321"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health &amp; Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA199792"],"award-info":[{"award-number":["U01CA199792"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health &amp; Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA199792"],"award-info":[{"award-number":["U01CA199792"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["RO1 CA090321"],"award-info":[{"award-number":["RO1 CA090321"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["RO1 CA172040"],"award-info":[{"award-number":["RO1 CA172040"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA199792"],"award-info":[{"award-number":["U01 CA199792"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["New Idea Award"],"award-info":[{"award-number":["New Idea Award"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Precursor B acute lymphoblastic leukemias (pre-B ALLs) abnormally express a specific glycan structure, 9-<jats:italic>O-<\/jats:italic>acetylated sialic acid (9<jats:italic>-O-<\/jats:italic>Ac-Sia), on their cell surface, but glycoproteins that carry this modification have not been identified. Using three different lectins that specifically recognize this structure, we establish that nucleolin (NCL), a protein implicated in cancer, contains 9-<jats:italic>O<\/jats:italic>-Ac-Sia. Surprisingly, antibodies against the glycolipid 9<jats:italic>-O-<\/jats:italic>Ac-Sia GD3 also detected 9<jats:italic>-O-<\/jats:italic>Ac-Sia NCL. NCL is present on the surface of pre-B ALL cells as a sialoglycoprotein that is partly 9-<jats:italic>O<\/jats:italic>-acetylated and conversely, 9-<jats:italic>O<\/jats:italic>-Ac-Sia-containing structures other than NCL are present on these cells as well. Interestingly, NCL and the 9<jats:italic>-O-<\/jats:italic>Ac-Sia signal had less co-localization on normal pre-B cells. We also investigated regulation of NCL on the cell surface and found that sialidase treatment increased the percentage of cells positive for cell surface NCL, suggesting that sialylation of NCL promotes internalization. Treatment of pre-B ALL cells with the chemotherapy drug vincristine also increased the percentage of cells with surface NCL and correlated with increased 9<jats:italic>-O-<\/jats:italic>Ac-Sia expression. All tested leukemia cells including primary samples expressed NCL, suggesting it as a possible therapeutic target. We confirmed this by showing inhibition of cell proliferation in some pre-B ALLs by exposure to a NCL-specific aptamer AS1411.<\/jats:p>","DOI":"10.1038\/s41598-018-33873-2","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T11:35:00Z","timestamp":1542281700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pre-B acute lymphoblastic leukemia expresses cell surface nucleolin as a 9-O-acetylated sialoglycoprotein"],"prefix":"10.1038","volume":"8","author":[{"given":"Eun Ji","family":"Joo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5442-3883","authenticated-orcid":false,"given":"Brian R","family":"Wasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Parrish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helicia","family":"Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"M\u03cbhlenhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Abdel-Azim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Groffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Heisterkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,21]]},"reference":[{"key":"33873_CR1","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1172\/JCI61203","volume":"122","author":"CG Mullighan","year":"2012","unstructured":"Mullighan, C. G. Molecular genetics of B-precursor acute lymphoblastic leukemia. J Clin Invest 122, 3407\u20133415, https:\/\/doi.org\/10.1172\/JCI61203 (2012).","journal-title":"J Clin Invest"},{"key":"33873_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/biot.200800253","volume":"4","author":"S Chowdhury","year":"2009","unstructured":"Chowdhury, S. & Mandal, C. O-acetylated sialic acids: multifaceted role in childhood acute lymphoblastic leukaemia. Biotechnology journal 4, 361\u2013374, https:\/\/doi.org\/10.1002\/biot.200800253 (2009).","journal-title":"Biotechnology journal"},{"key":"33873_CR3","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1084\/jem.20121482","volume":"210","author":"R Parameswaran","year":"2013","unstructured":"Parameswaran, R. et al. O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia. The Journal of experimental medicine 210, 805\u2013819, https:\/\/doi.org\/10.1084\/jem.20121482 (2013).","journal-title":"The Journal of experimental medicine"},{"key":"33873_CR4","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1158\/0008-5472.CAN-14-0728","volume":"74","author":"C Bull","year":"2014","unstructured":"Bull, C., Stoel, M. A., den Brok, M. H. & Adema, G. J. Sialic acids sweeten a tumor\u2019s life. Cancer research 74, 3199\u20133204, https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0728 (2014).","journal-title":"Cancer research"},{"key":"33873_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/glycob\/cwv097","volume":"26","author":"OM Pearce","year":"2016","unstructured":"Pearce, O. M. & Laubli, H. Sialic acids in cancer biology and immunity. Glycobiology 26, 111\u2013128, https:\/\/doi.org\/10.1093\/glycob\/cwv097 (2016).","journal-title":"Glycobiology"},{"key":"33873_CR6","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1016\/j.bbagen.2014.06.006","volume":"1840","author":"F Dall\u2019Olio","year":"2014","unstructured":"Dall\u2019Olio, F., Malagolini, N., Trinchera, M. & Chiricolo, M. Sialosignaling: sialyltransferases as engines of self-fueling loops in cancer progression. Biochimica et biophysica acta 1840, 2752\u20132764, https:\/\/doi.org\/10.1016\/j.bbagen.2014.06.006 (2014).","journal-title":"Biochimica et biophysica acta"},{"key":"33873_CR7","unstructured":"Varki, A. & Schauer, R. In Essentials of Glycobiology (eds A. Varki et al.) (2009)."},{"key":"33873_CR8","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.tim.2016.07.005","volume":"24","author":"BR Wasik","year":"2016","unstructured":"Wasik, B. R., Barnard, K. N. & Parrish, C. R. Effects of Sialic Acid Modifications on Virus Binding and Infection. Trends in microbiology 24, 991\u20131001, https:\/\/doi.org\/10.1016\/j.tim.2016.07.005 (2016).","journal-title":"Trends in microbiology"},{"key":"33873_CR9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1177\/1060028016632013","volume":"50","author":"C Ploessl","year":"2016","unstructured":"Ploessl, C., Pan, A., Maples, K. T. & Lowe, D. K. Dinutuximab: An Anti-GD2 Monoclonal Antibody for High-Risk Neuroblastoma. The Annals of pharmacotherapy 50, 416\u2013422, https:\/\/doi.org\/10.1177\/1060028016632013 (2016).","journal-title":"The Annals of pharmacotherapy"},{"key":"33873_CR10","doi-asserted-by":"publisher","first-page":"5604891","DOI":"10.1155\/2017\/5604891","volume":"2017","author":"J Fleurence","year":"2017","unstructured":"Fleurence, J. et al. Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy. Journal of immunology research 2017, 5604891, https:\/\/doi.org\/10.1155\/2017\/5604891 (2017).","journal-title":"Journal of immunology research"},{"key":"33873_CR11","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1073\/pnas.1604721113","volume":"113","author":"SC Yeh","year":"2016","unstructured":"Yeh, S. C. et al. Glycolipid GD3 and GD3 synthase are key drivers for glioblastoma stem cells and tumorigenicity. Proceedings of the National Academy of Sciences of the United States of America 113, 5592\u20135597, https:\/\/doi.org\/10.1073\/pnas.1604721113 (2016).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"33873_CR12","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1200\/jco.2001.19.19.3976","volume":"19","author":"AM Scott","year":"2001","unstructured":"Scott, A. M. et al. Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 19, 3976\u20133987, https:\/\/doi.org\/10.1200\/jco.2001.19.19.3976 (2001).","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"33873_CR13","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1016\/S0021-9258(17)39429-2","volume":"260","author":"MH Ravindranath","year":"1985","unstructured":"Ravindranath, M. H., Higa, H. H., Cooper, E. L. & Paulson, J. C. Purification and characterization of an O-acetylsialic acid-specific lectin from a marine crab Cancer antennarius. The Journal of biological chemistry 260, 8850\u20138856 (1985).","journal-title":"The Journal of biological chemistry"},{"key":"33873_CR14","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/S0021-9258(19)77987-3","volume":"263","author":"MH Ravindranaths","year":"1988","unstructured":"Ravindranaths, M. H., Paulson, J. C. & Irie, R. F. Human melanoma antigen O-acetylated ganglioside GD3 is recognized by Cancer antennarius lectin. The Journal of biological chemistry 263, 2079\u20132086 (1988).","journal-title":"The Journal of biological chemistry"},{"key":"33873_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/bs.apcsb.2017.08.001","volume":"111","author":"I Ugrinova","year":"2018","unstructured":"Ugrinova, I., Petrova, M., Chalabi-Dchar, M. & Bouvet, P. Multifaceted Nucleolin Protein and Its Molecular Partners in Oncogenesis. Adv Protein Chem Struct Biol 111, 133\u2013164, https:\/\/doi.org\/10.1016\/bs.apcsb.2017.08.001 (2018).","journal-title":"Adv Protein Chem Struct Biol"},{"key":"33873_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2017.07.025","volume":"186","author":"W Jia","year":"2017","unstructured":"Jia, W., Yao, Z., Zhao, J., Guan, Q. & Gao, L. New perspectives of physiological and pathological functions of nucleolin (NCL). Life Sci 186, 1\u201310, https:\/\/doi.org\/10.1016\/j.lfs.2017.07.025 (2017).","journal-title":"Life Sci"},{"key":"33873_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28846-4","volume":"8","author":"ML Massimino","year":"2018","unstructured":"Massimino, M. L. et al. Cell surface nucleolin interacts with and internalizes Bothrops asper Lys49 phospholipase A2 and mediates its toxic activity. Sci Rep 8, 10619, https:\/\/doi.org\/10.1038\/s41598-018-28846-4 (2018).","journal-title":"Sci Rep"},{"key":"33873_CR18","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cell.2018.05.043","volume":"174","author":"M Percharde","year":"2018","unstructured":"Percharde, M. et al. A LINE1-Nucleolin Partnership Regulates Early Development and ESC Identity. Cell 174, 391\u2013405 e319, https:\/\/doi.org\/10.1016\/j.cell.2018.05.043 (2018).","journal-title":"Cell"},{"key":"33873_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1074\/jbc.M112.387076","volume":"288","author":"M Koutsioumpa","year":"2013","unstructured":"Koutsioumpa, M. et al. Interplay between alphavbeta3 integrin and nucleolin regulates human endothelial and glioma cell migration. The Journal of biological chemistry 288, 343\u2013354, https:\/\/doi.org\/10.1074\/jbc.M112.387076 (2013).","journal-title":"The Journal of biological chemistry"},{"key":"33873_CR20","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1182\/blood-2012-12-471094","volume":"121","author":"JF Wise","year":"2013","unstructured":"Wise, J. F. et al. Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex. Blood 121, 4729\u20134739, https:\/\/doi.org\/10.1182\/blood-2012-12-471094 (2013).","journal-title":"Blood"},{"key":"33873_CR21","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.celrep.2016.07.005","volume":"16","author":"RB Perry","year":"2016","unstructured":"Perry, R. B. et al. Nucleolin-Mediated RNA Localization Regulates Neuron Growth and Cycling Cell Size. Cell reports 16, 1664\u20131676, https:\/\/doi.org\/10.1016\/j.celrep.2016.07.005 (2016).","journal-title":"Cell reports"},{"key":"33873_CR22","doi-asserted-by":"publisher","first-page":"e0170160","DOI":"10.1371\/journal.pone.0170160","volume":"12","author":"V Marcel","year":"2017","unstructured":"Marcel, V. et al. Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients. PloS one 12, e0170160, https:\/\/doi.org\/10.1371\/journal.pone.0170160 (2017).","journal-title":"PloS one"},{"key":"33873_CR23","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1182\/blood-2006-08-043257","volume":"109","author":"Y Otake","year":"2007","unstructured":"Otake, Y. et al. Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood 109, 3069\u20133075, https:\/\/doi.org\/10.1182\/blood-2006-08-043257 (2007).","journal-title":"Blood"},{"key":"33873_CR24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/leu.2017.215","volume":"32","author":"N Jain","year":"2018","unstructured":"Jain, N. et al. Targeting nucleolin for better survival in diffuse large B-cell lymphoma. Leukemia 32, 663\u2013674, https:\/\/doi.org\/10.1038\/leu.2017.215 (2018).","journal-title":"Leukemia"},{"key":"33873_CR25","doi-asserted-by":"publisher","first-page":"7181","DOI":"10.1158\/0008-5472.CAN-16-0300","volume":"76","author":"ME Gilles","year":"2016","unstructured":"Gilles, M. E. et al. Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature. Cancer research 76, 7181\u20137193, https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0300 (2016).","journal-title":"Cancer research"},{"key":"33873_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/B978-0-12-800097-7.00003-8","volume":"308","author":"M Cohen","year":"2014","unstructured":"Cohen, M. & Varki, A. Modulation of glycan recognition by clustered saccharide patches. Int Rev Cell Mol Biol 308, 75\u2013125, https:\/\/doi.org\/10.1016\/B978-0-12-800097-7.00003-8 (2014).","journal-title":"Int Rev Cell Mol Biol"},{"key":"33873_CR27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1128\/iai.60.1.56-62.1992","volume":"60","author":"KM Abdullah","year":"1992","unstructured":"Abdullah, K. M., Udoh, E. A., Shewen, P. E. & Mellors, A. A neutral glycoprotease of Pasteurella haemolytica A1 specifically cleaves O-sialoglycoproteins. Infection and immunity 60, 56\u201362 (1992).","journal-title":"Infection and immunity"},{"key":"33873_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0167-7799(94)90006-X","volume":"12","author":"A Mellors","year":"1994","unstructured":"Mellors, A. & Sutherland, D. R. Tools to cleave glycoproteins. Trends in biotechnology 12, 15\u201318, https:\/\/doi.org\/10.1016\/0167-7799(94)90006-X (1994).","journal-title":"Trends in biotechnology"},{"key":"33873_CR29","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1021\/acschembio.6b00928","volume":"12","author":"Z Khedri","year":"2017","unstructured":"Khedri, Z. et al. A Chemical Biology Solution to Problems with Studying Biologically Important but Unstable 9-O-Acetyl Sialic Acids. ACS chemical biology 12, 214\u2013224, https:\/\/doi.org\/10.1021\/acschembio.6b00928 (2017).","journal-title":"ACS chemical biology"},{"key":"33873_CR30","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.celrep.2015.05.044","volume":"11","author":"MA Langereis","year":"2015","unstructured":"Langereis, M. A. et al. Complexity and Diversity of the Mammalian Sialome Revealed by Nidovirus Virolectins. Cell reports 11, 1966\u20131978, https:\/\/doi.org\/10.1016\/j.celrep.2015.05.044 (2015).","journal-title":"Cell reports"},{"key":"33873_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.yexcr.2008.10.039","volume":"315","author":"ME Losfeld","year":"2009","unstructured":"Losfeld, M. E. et al. The cell surface expressed nucleolin is a glycoprotein that triggers calcium entry into mammalian cells. Experimental cell research 315, 357\u2013369, https:\/\/doi.org\/10.1016\/j.yexcr.2008.10.039 (2009).","journal-title":"Experimental cell research"},{"key":"33873_CR32","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.bbagen.2016.12.015","volume":"1861","author":"PJ Bates","year":"2017","unstructured":"Bates, P. J. et al. G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms. Biochimica et biophysica acta 1861, 1414\u20131428, https:\/\/doi.org\/10.1016\/j.bbagen.2016.12.015 (2017).","journal-title":"Biochimica et biophysica acta"},{"key":"33873_CR33","doi-asserted-by":"publisher","first-page":"e15787","DOI":"10.1371\/journal.pone.0015787","volume":"5","author":"AG Hovanessian","year":"2010","unstructured":"Hovanessian, A. G. et al. Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization. PloS one 5, e15787, https:\/\/doi.org\/10.1371\/journal.pone.0015787 (2010).","journal-title":"PloS one"},{"key":"33873_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8673","volume":"6","author":"AM Baumann","year":"2015","unstructured":"Baumann, A. M. et al. 9-O-Acetylation of sialic acids is catalysed by CASD1 via a covalent acetyl-enzyme intermediate. Nature communications 6, 7673, https:\/\/doi.org\/10.1038\/ncomms8673 (2015).","journal-title":"Nature communications"},{"key":"33873_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13046-018-0721-7","volume":"37","author":"H Paz","year":"2018","unstructured":"Paz, H. et al. Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008. J Exp Clin Cancer Res 37, 67, https:\/\/doi.org\/10.1186\/s13046-018-0721-7 (2018).","journal-title":"J Exp Clin Cancer Res"},{"key":"33873_CR36","doi-asserted-by":"publisher","first-page":"11378","DOI":"10.18632\/oncotarget.3409","volume":"6","author":"F Fei","year":"2015","unstructured":"Fei, F. et al. B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3. Oncotarget 6, 11378\u201311394, https:\/\/doi.org\/10.18632\/oncotarget.3409 (2015).","journal-title":"Oncotarget"},{"key":"33873_CR37","doi-asserted-by":"publisher","first-page":"618","DOI":"10.4161\/onci.20249","volume":"1","author":"N Feldhahn","year":"2012","unstructured":"Feldhahn, N. et al. Environment-mediated drug resistance in Bcr\/Abl-positive acute lymphoblastic leukemia. Oncoimmunology 1, 618\u2013629, https:\/\/doi.org\/10.4161\/onci.20249 (2012).","journal-title":"Oncoimmunology"},{"key":"33873_CR38","doi-asserted-by":"publisher","first-page":"e2518","DOI":"10.1371\/journal.pone.0002518","volume":"3","author":"D Destouches","year":"2008","unstructured":"Destouches, D. et al. Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin. PloS one 3, e2518, https:\/\/doi.org\/10.1371\/journal.pone.0002518 (2008).","journal-title":"PloS one"},{"key":"33873_CR39","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10059-013-0149-z","volume":"36","author":"J Bi","year":"2013","unstructured":"Bi, J. et al. Identification of nucleolin as a lipid-raft-dependent beta1-integrin-interacting protein in A375 cell migration. Molecules and cells 36, 507\u2013517, https:\/\/doi.org\/10.1007\/s10059-013-0149-z (2013).","journal-title":"Molecules and cells"},{"key":"33873_CR40","doi-asserted-by":"publisher","first-page":"8617","DOI":"10.1158\/0008-5472.CAN-10-0920","volume":"70","author":"EM Reyes-Reyes","year":"2010","unstructured":"Reyes-Reyes, E. M., Teng, Y. & Bates, P. J. A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism. Cancer research 70, 8617\u20138629, https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-0920 (2010).","journal-title":"Cancer research"},{"key":"33873_CR41","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1021\/bi047831s","volume":"44","author":"M Carpentier","year":"2005","unstructured":"Carpentier, M. et al. Nucleolin undergoes partial N- and O-glycosylations in the extranuclear cell compartment. Biochemistry 44, 5804\u20135815, https:\/\/doi.org\/10.1021\/bi047831s (2005).","journal-title":"Biochemistry"},{"key":"33873_CR42","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1111\/j.1742-4658.2011.08180.x","volume":"278","author":"ME Losfeld","year":"2011","unstructured":"Losfeld, M. E. et al. N-Glycosylation influences the structure and self-association abilities of recombinant nucleolin. The FEBS journal 278, 2552\u20132564, https:\/\/doi.org\/10.1111\/j.1742-4658.2011.08180.x (2011).","journal-title":"The FEBS journal"},{"key":"33873_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1081\/IMM-100104017","volume":"30","author":"DA Fox","year":"2001","unstructured":"Fox, D. A. et al. The T lymphocyte structure CD60 contains a sialylated carbohydrate epitope that is expressed on both gangliosides and glycoproteins. Immunological investigations 30, 67\u201385 (2001).","journal-title":"Immunological investigations"},{"key":"33873_CR44","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/jnr.21264","volume":"85","author":"CR Yang","year":"2007","unstructured":"Yang, C. R., Liour, S. S., Dasgupta, S. & Yu, R. K. Inhibition of neuronal migration by JONES antibody is independent of 9-O-acetyl GD3 in GD3-synthase knockout mice. Journal of neuroscience research 85, 1381\u20131390, https:\/\/doi.org\/10.1002\/jnr.21264 (2007).","journal-title":"Journal of neuroscience research"},{"key":"33873_CR45","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1515\/bchm3.1986.367.1.433","volume":"367","author":"AP Corfield","year":"1986","unstructured":"Corfield, A. P., Sander-Wewer, M., Veh, R. W., Wember, M. & Schauer, R. The action of sialidases on substrates containing O-acetylsialic acids. Biological chemistry Hoppe-Seyler 367, 433\u2013439 (1986).","journal-title":"Biological chemistry Hoppe-Seyler"},{"key":"33873_CR46","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2478\/s11658-014-0206-4","volume":"19","author":"D Hoja-Lukowicz","year":"2014","unstructured":"Hoja-Lukowicz, D., Kedracka-Krok, S., Duda, W. & Litynska, A. The lectin-binding pattern of nucleolin and its interaction with endogenous galectin-3. Cellular & molecular biology letters 19, 461\u2013482, https:\/\/doi.org\/10.2478\/s11658-014-0206-4 (2014).","journal-title":"Cellular & molecular biology letters"},{"key":"33873_CR47","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.devcel.2008.05.005","volume":"15","author":"G Yogalingam","year":"2008","unstructured":"Yogalingam, G. et al. Neuraminidase 1 is a negative regulator of lysosomal exocytosis. Developmental cell 15, 74\u201386, https:\/\/doi.org\/10.1016\/j.devcel.2008.05.005 (2008).","journal-title":"Developmental cell"},{"key":"33873_CR48","doi-asserted-by":"publisher","first-page":"8661","DOI":"10.1073\/pnas.1507712112","volume":"112","author":"B Shao","year":"2015","unstructured":"Shao, B. et al. O-glycans direct selectin ligands to lipid rafts on leukocytes. Proceedings of the National Academy of Sciences of the United States of America 112, 8661\u20138666, https:\/\/doi.org\/10.1073\/pnas.1507712112 (2015).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"33873_CR49","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/s41375-018-0090-4","volume":"32","author":"C Mahotka","year":"2018","unstructured":"Mahotka, C., Bhatia, S., Kollet, J. & Grinstein, E. Nucleolin promotes execution of the hematopoietic stem cell gene expression program. Leukemia 32, 1865\u20131868, https:\/\/doi.org\/10.1038\/s41375-018-0090-4 (2018).","journal-title":"Leukemia"},{"key":"33873_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25816-8","volume":"8","author":"S Romano","year":"2018","unstructured":"Romano, S., Moura, V., Simoes, S., Moreira, J. N. & Goncalves, J. Anticancer activity and antibody-dependent cell-mediated cytotoxicity of novel anti-nucleolin antibodies. Sci Rep 8, 7450, https:\/\/doi.org\/10.1038\/s41598-018-25816-8 (2018).","journal-title":"Sci Rep"},{"key":"33873_CR51","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature09883","volume":"473","author":"C Duy","year":"2011","unstructured":"Duy, C. et al. BCL6 enables Ph+\u2009acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. Nature 473, 384\u2013388, https:\/\/doi.org\/10.1038\/nature09883 (2011).","journal-title":"Nature"},{"key":"33873_CR52","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ccell.2015.02.003","volume":"27","author":"H Geng","year":"2015","unstructured":"Geng, H. et al. Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia. Cancer cell 27, 409\u2013425, https:\/\/doi.org\/10.1016\/j.ccell.2015.02.003 (2015).","journal-title":"Cancer cell"},{"key":"33873_CR53","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1158\/0008-5472.CAN-10-0300","volume":"70","author":"R Parameswaran","year":"2010","unstructured":"Parameswaran, R., Muschen, M., Kim, Y. M., Groffen, J. & Heisterkamp, N. A functional receptor for B-cell-activating factor is expressed on human acute lymphoblastic leukemias. Cancer research 70, 4346\u20134356, https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-0300 (2010).","journal-title":"Cancer research"},{"key":"33873_CR54","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ccell.2015.05.008","volume":"28","author":"S Shojaee","year":"2015","unstructured":"Shojaee, S. et al. Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia. Cancer cell 28, 114\u2013128, https:\/\/doi.org\/10.1016\/j.ccell.2015.05.008 (2015).","journal-title":"Cancer cell"},{"key":"33873_CR55","doi-asserted-by":"publisher","first-page":"e0137917","DOI":"10.1371\/journal.pone.0137917","volume":"10","author":"AA George","year":"2015","unstructured":"George, A. A. et al. Phosphoflow-Based Evaluation of Mek Inhibitors as Small-Molecule Therapeutics for B-Cell Precursor Acute Lymphoblastic Leukemia. PloS one 10, e0137917, https:\/\/doi.org\/10.1371\/journal.pone.0137917 (2015).","journal-title":"PloS one"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33873-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33873-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33873-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:58:38Z","timestamp":1671623918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33873-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,21]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["33873"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-33873-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,21]]},"assertion":[{"value":"16 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17174"}}